IP Verse

Competitive analysis in Protein Production industry

Latest patents granted in the Protein Production industry

Patent:
EP3150699
Grant Date:
Aug 21, 2024
Title:
Culture Medium Containing Uridine And N-Acetyl-D-Mannosamine
Applicant:
JCR PHARMACEUTICALS CO., LTD.
Patent:
EP2634243
Grant Date:
Jul 24, 2024
Title:
Improved Process For The Culturing Of Cells
Applicant:
DPX HOLDINGS B.V.
Patent:
EP3296395
Grant Date:
Jun 19, 2024
Title:
Multiple Antigen Binding Molecular Fusion, Pharmaceutical Composition, Method For Identifying Linear Epitope, And Method For Preparing Multiple Antigen Binding Molecular Fusion
Applicant:
CHUGAI SEIYAKU KABUSHIKI KAISHA
Patent:
EP3085780
Grant Date:
Jun 28, 2023
Title:
Producing Hybrid Antibodies Containing Human Variable Regions And Rodent Constant Regions
Applicant:
REGENERON PHARMACEUTICALS, INC.
Patent:
EP2314686
Grant Date:
Jun 21, 2023
Title:
Cells Producing Antibody Compositions
Applicant:
KYOWA HAKKO KIRIN CO., LTD.
Patent:
EP3085779
Grant Date:
May 31, 2023
Title:
Method Of Modifying Eukaryotic Cells
Applicant:
REGENERON PHARMACEUTICALS, INC.
Patent:
EP3250681
Grant Date:
May 3, 2023
Title:
Compositions And Methods For T Cell Delivery Of Therapeutic Molecules
Applicant:
THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
Patent:
EP3434760
Grant Date:
Apr 26, 2023
Title:
Methods For Increasing Mannose Content Of Recombinant Proteins
Applicant:
AMGEN INC.
Patent:
EP3769781
Grant Date:
Apr 19, 2023
Title:
Stable Anti-Ifnar1 Formulation
Applicant:
ASTRAZENECA AB
Patent:
EP3064508
Grant Date:
Mar 15, 2023
Title:
Method Of Producing Recombinant High Molecular Weight Vwf In Cell Culture
Applicant:
BAXALTA GMBH

Top patents facing oppositions in Protein Production industry

Patent:
EP2971040
Grant Date:
Sep 19, 2018
Title:
Methods Of Cell Culture
Applicant:
MOMENTA PHARMACEUTICALS, INC.
Oppositions:
20
Patent:
EP2791160
Grant Date:
Mar 2, 2022
Title:
Modified Nucleoside, Nucleotide, And Nucleic Acid Compositions
Applicant:
MODERNA THERAPEUTICS, INC.
Oppositions:
20
Patent:
EP2154244
Grant Date:
Apr 12, 2017
Title:
Cell Culture Method Using Amino Acid-Enriched Medium
Applicant:
CHUGAI SEIYAKU KABUSHIKI KAISHA
Oppositions:
15
Patent:
EP3330370
Grant Date:
Feb 24, 2021
Title:
Process For Cultivation Of Cho Cells
Applicant:
NOVARTIS AG
Oppositions:
12
Patent:
EP2501822
Grant Date:
Aug 16, 2017
Title:
Methods For Enhanced Protein Production
Applicant:
E. R. SQUIBB & SONS, L.L.C.
Oppositions:
12
Patent:
EP3227454
Grant Date:
Jan 29, 2020
Title:
Process For Manipulating The Level Of Glycan Content Of A Glycoprotein
Applicant:
AMGEN INC.
Oppositions:
10
Patent:
EP2634250
Grant Date:
Apr 5, 2017
Title:
Improved Process For The Culturing Of Cells
Applicant:
DSM IP ASSETS B.V.
Oppositions:
9
Patent:
EP2634242
Grant Date:
Apr 5, 2017
Title:
Improved Process For The Culturing Of Cells
Applicant:
PATHEON HOLDINGS I B.V.
Oppositions:
9
Patent:
EP2634243
Grant Date:
Jul 24, 2024
Title:
Improved Process For The Culturing Of Cells
Applicant:
DPX HOLDINGS B.V.
Oppositions:
9
Patent:
EP2809773
Grant Date:
Sep 2, 2020
Title:
Process Of Modulating Man5 And/Or Afucosylation Content Of Glycoprotein Composition
Applicant:
DR. REDDY'S LABORATORIES LIMITED
Oppositions:
5

Top companies filing oppositions in Protein Production industry

Company:
STRAWMAN LIMITED
Total oppositions filed:
26
Company:
MAIWALD GMBH
Total oppositions filed:
16
Company:
HOFFMANN EITLE
Total oppositions filed:
10
Company:
KYMAB LIMITED
Total oppositions filed:
7
Company:
NEUEFEIND, REGINA
Total oppositions filed:
7
Company:
JAMES POOLE LIMITED
Total oppositions filed:
6
Company:
BAYER INTELLECTUAL PROPERTY GMBH
Total oppositions filed:
4
Company:
OETKE, CORNELIA
Total oppositions filed:
4
Company:
BREUER, MARKUS
Total oppositions filed:
4
Company:
REGENERON PHARMACEUTICALS, INC.
Total oppositions filed:
4

Top companies facing oppositions in Protein Production industry

Company:
MOMENTA PHARMACEUTICALS, INC.
Total facing oppositions:
24
Company:
CHUGAI SEIYAKU KABUSHIKI KAISHA
Total facing oppositions:
24
Company:
AMGEN INC.
Total facing oppositions:
16
Company:
NOVARTIS AG
Total facing oppositions:
13
Company:
MODERNA THERAPEUTICS, INC.
Total facing oppositions:
10
Company:
MODERNATX, INC.
Total facing oppositions:
10
Company:
DPX HOLDINGS B.V.
Total facing oppositions:
9
Company:
DSM IP ASSETS B.V.
Total facing oppositions:
9
Company:
PATHEON HOLDINGS I B.V.
Total facing oppositions:
9
Company:
REGENERON PHARMACEUTICALS, INC.
Total facing oppositions:
7

Need more information?

Feel free to send us a message here and we will get back to you